CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 136 enrolled
Drug / intervention
BLI800 +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00856843
NCT00856843Phase 3Completed

BLI800-303: An Efficacy Evaluation of 2 Different Bowel Cleansing Preparations in Adult Subjects

Braintree Laboratories·interventional·Posted Mar 6, 2009·Updated Nov 10, 2010

In Brief

A Phase 3 clinical trial evaluating BLI800 and Polyethylene glycol 3350 based bowel preparation for Colonoscopy. Completed, enrolled 136 participants across 5 sites.

Detailed Summary

To evaluate the safety and efficacy of BLI800 vs an FDA approved bowel preparation before colonoscopic examination in adult subjects.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsColonoscopy
CountriesUnited States
Collaborators--

Timeline

Phase 3CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedMar 6, 2009
Enrollment StartFeb 1, 2009
Primary CompletionMay 1, 2009
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 17.3 years ago

Interventions

BLI800drug

Solution for oral administration prior to colonoscopy

Polyethylene glycol 3350 based bowel preparationdrug

Solution for oral administration prior to colonoscopy